Sfoglia per RIVISTA
NATURE COMMUNICATIONS
Collezione AO Cuneo
Items : 1
Bemcentinib as monotherapy and in combination with low-dose cytarabine in acute myeloid leukemia patients unfit for intensive chemotherapy: a phase 1b/2a trial. in Nature communications / Nat Commun. 2025 Mar 23;16(1):2846. doi: 10.1038/s41467-025-58179-6.
2025
AO Cuneo
Loges S; Heuser M; Chromik J; Sutamtewagul G; Kapp-Schwoerer S; Crugnola M; Di Renzo N; Lemoli R; Mattei D; Fiedler W; Alvarado-Valero Y; Ben-Batalla I; Waizenegger J; Rieckmann LM; Janning M; Collienne M; Imbusch CD; Beumer N; Micklem D; H Nilsson L; Madeleine N; McCracken N; Oliva C; Gorcea-Carson C; Gjertsen BT;